ATMS   $0.498  66.61% Market Closed

Artemis Therapeutics Inc
Total Cash
totalCashPerShare
EBITDA
Total Debt
quickRatio
currentRatio
Total Revenue
debtToEquity
Revenue/Share 0.005
ROA
ROE
grossProfits 257.00K
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 55.79M
forwardPE
floatShares
sharesOutstanding 112.03M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.87%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.009
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon
trailingEps 0.0
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated July 16, 2023, 5:10 p.m.